BILL ANALYSIS                                                                                                                                                                                                    �



                                                                  SB 977
                                                                  Page  1


          (  Without Reference to File  )

          SENATE THIRD READING
          SB 977 (Yee)
          As Amended August 31, 2012
          Majority vote

           SENATE VOTE  :36-0  
           
           HEALTH              12-2                                        
           
           -------------------------------- 
          |Ayes:|Pan, Ammiano, Atkins,     |
          |     |Eng, Gordon, Hayashi,     |
          |     |Bonnie Lowenthal,         |
          |     |Mansoor, Mitchell,        |
          |     |Monning,                  |
          |     |V. Manuel P�rez, Silva    |
          |     |                          |
          |-----+--------------------------|
          |Nays:|Logue, Nestande           |
          |     |                          |
           -------------------------------- 

           SUMMARY  :  Subjects a manufacturer of nail polish that violates 
          provisions of existing law governing misbranded cosmetics, if 
          convicted, to a maximum fine of $2,000 and/or imprisonment for 
          one year in the county jail.  Clarifies that the provisions of 
          this bill shall not apply to nail salons or to distributors, 
          retailers or wholesalers of nail polish.   

           FISCAL EFFECT  :  None

           COMMENTS  :  The author points to a recent report by the 
          Department of Toxic Substances Control (DTSC) that found that 
          ingredients listed on the labels of some nail polishes did not 
          accurately reflect the products' chemical composition as 
          evidence of the need for this bill.  The author states that this 
          bill is intended to influence the bad behavior of some nail 
          polish manufacturers by imposing a greater monetary disincentive 
          against mislabeling or misrepresenting their ingredients.  In 
          addition, the author points out that the provisions of this bill 
          will not apply to nail salons or to distributors, retailers or 
          wholesalers of nail polish.  According to the author, this bill 








                                                                  SB 977
                                                                  Page  2


          attempts to address a health and public safety risk to consumers 
          and to nail salon workers, in particular, who are exposed to the 
          chemicals in nail polish on a daily basis and deserve to be 
          informed of what is in the products they use.  

          According to the DTSC, nail products containing the "toxic-trio" 
          of the chemicals called dibutyl phthalate (DBP), toluene, and 
          formaldehyde pose health and safety risks to roughly 121,000 
          nail salon technicians in more than 48,000 salons throughout 
          California.  These chemicals have been the subject of ongoing 
          public scrutiny from non-government organizations, environmental 
          and worker rights groups, and various regulatory agencies over 
          concerns about nail product safety.  Exposure to toxic-trio 
          chemicals is associated with cancer, birth defects, asthma, and 
          other chronic health conditions.

          In May 2011, DTSC conducted a limited-scale sampling of nail 
          products offered for sale in the San Francisco Bay Area in an 
          effort to further support a local ordinance establishing a 
          voluntary recognition program for nail salons that choose safer 
          nail products.  DTSC's objective in sampling the products was to 
          investigate the accuracy of claims made by a small number of 
          nail product manufacturers that their goods were free of some or 
          all toxic-trio chemicals; provide information on hazardous 
          chemicals used in these products; and, examine trends of 
          possible ingredient substitutions.  Twenty-five nail product 
          samples, which included both products with toxic-trio related 
          claims and those with no claims about chemical content, were 
          randomly collected from six distributors and tested.  
          Manufacturers of 12 of the 25 products claimed that they were 
          free of at least one toxic-trio chemical and that seven claimed 
          to contain none of the toxic-trio chemicals.  

          In five of the seven products that claimed to be free of all of 
          the toxic-trio chemicals, DTSC found that the products contained 
          high levels of DBP, toluene, or a combination of both.  DTSC 
          also found chemicals in the nail products whose functionality, 
          toxicities, environmental behavior, and exposure risks remain 
          unknown and stated that these unknown chemicals may be 
          alternatives to the toxic-trio.  Based on the findings of its 
          study, DTSC recommended that manufacturers disclose nail product 
          formulations and provide information demonstrating that 
          substitutions are safer to public health and the environment.  
          DTSC also urged more collaboration and coordination among 








                                                                  SB 977
                                                                  Page  3


          interested stakeholders, in addition to expanded outreach, 
          education, and training of nail salon owners and workers.

          The Personal Care Products Council states in support of a prior 
          version of this bill, which contained a $15,000 fine, that this 
          bill will protect consumers from misleading claims and 
          advertisements concerning nail polish.


           Analysis Prepared by  :    Cassie Royce / HEALTH / (916) 319-2097 


                                                                FN: 0005858